Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism

Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ

(2014) Xiujing Feng et al.   BIOCHEMICAL PHARMACOLOGY

8-Hydroxy-2′-Deoxyguanosine and Cardiovascular Disease: a Systematic Review

(2014) Lona J. Kroese et al.   Current Atherosclerosis Reports

Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis

(2014) Eman M. Mantawy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

l-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression

(2013) Sonia Zambrano et al.   BIOCHEMICAL PHARMACOLOGY

Type 5 Adenylyl Cyclase Increases Oxidative Stress by Transcriptional Regulation of Manganese Superoxide Dismutase via the SIRT1/FoxO3a Pathway

(2013) Lo Lai et al.   CIRCULATION

PPARγ signaling and metabolism: the good, the bad and the future

(2013) Maryam Ahmadian et al.   NATURE MEDICINE

Regulation of Heat Shock Proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens Myocardial Injury and Dysfunction In Vivo after Ischemia/Reperfusion

(2013) Neha Rani et al.   PLoS One

Chrysin promotes osteogenic differentiation via ERK/MAPK activation

(2013) Wenfeng Zeng et al.   Protein & Cell

Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes

(2012) Chin-Shiu Huang et al.   ARCHIVES OF TOXICOLOGY

Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists

(2012) Yi-Lei Deng et al.   Hepatobiliary & Pancreatic Diseases International

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty

(2012) Janice V. Huang et al.   JOURNAL OF LIPID RESEARCH

Valsartan, an Angiotensin II Receptor Blocker, Attenuates Cardiac Dysfunction and Oxidative Stress in Isoproterenol-Induced Cardiotoxicity

(2011) Sameer Goyal et al.   Cardiovascular Toxicology

8-Hydroxy-2′-deoxyguanosine is a prognostic mediator for cardiac event

(2011) Satoshi Suzuki et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs

(2011) Huey-Ming Lo et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma

(2011) Yasuhiro Maejima et al.   LABORATORY INVESTIGATION

Reduction of isoprenaline-induced myocardial TGF-β1 expression and fibrosis in osthole-treated mice

(2011) Rong Chen et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Chrysin suppresses mast cell-mediated allergic inflammation: Involvement of calcium, caspase-1 and nuclear factor-κB

(2011) Yunju Bae et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

PPAR-γ Agonism for Cardiovascular and Renal Protection

(2010) Pantelis A. Sarafidis et al.   Cardiovascular Therapeutics

Transforming growth factor (TGF)-β signaling in cardiac remodeling

(2010) Marcin Dobaczewski et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats

(2010) Jayanthi Sathiavelu et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-κB and JNK activations in microglia cells

(2010) Sang Keun Ha et al.   NEUROSCIENCE LETTERS

Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale

(2010) Beth A. Rose et al.   PHYSIOLOGICAL REVIEWS

The PPAR trio: Regulators of myocardial energy metabolism in health and disease

(2008) Jose A. Madrazo et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY